Interventional Cardiology News and Research

RSS

Back from the dead twice

“I died twice,” says a teary-eyed DeWayne Lark, “If I didn't believe in miracles before, I believe in them now.”

20 Feb 2009

Researcher develops method to combat congenital heart disease in children

Congenital heart defects account for five times more deaths annually than all childhood cancers combined.

9 Feb 2009

Timing is everything for some heart attack patients

There is strong evidence that getting to the hospital quickly during a heart attack is critical, since early treatment saves both lives and heart muscle. And if the responsible coronary artery is completely blocked, it should be opened as soon as possible.

11 Nov 2008

Fibrin-derived peptide FX06 reduces cardiac reperfusion injury

Data presented today at the European Society of Cardiology Congress demonstrates the effectiveness of a peptide called FX06 in preventing cardiac damage resulting from treatment following a heart attack.

2 Sep 2008

Drug eluting stents: New elements in the debate

Results announced at the 2006 ESC meeting in Barcelona questioned the long-term safety of drug eluting stents (DES) and sparked intense discussion.

31 Aug 2008

Who needs cardiac surgery?

Throughout the developed world, cardiac surgery faces increasing challenges from percutaneous intervention, currently with revascularisation, but potentially soon for valve replacement as well. The spectacular growth of PCI in the UK over the last five years is typical for many developed countries.

31 Aug 2008

Patients arriving at hospitals in daytime hours get faster, better care compared to off hours

Patients hospitalized with heart attacks tend to get faster and more comprehensive care if they arrive during daytime hours, according to a report in Circulation: Journal of the American Heart Association.

21 Apr 2008

Matrix registry probes adherence to clopidogrel at 1 year

A large community-based registry of patients treated with drug-eluting stents is providing important insight into how long patients with complex coronary artery disease typically stick to their doctors' orders to take clopidogrel, a drug that prevents unwanted blood clots; why they stop taking the drug; and the long-term consequences of that decision.

1 Apr 2008

First clinical trial data of a fully bioabsorbable drug-eluting stent

Data published today in The Lancet from ABSORB, the world's first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery disease, demonstrated no stent thrombosis, no clinically driven target lesion revascularizations (re-treatment of a diseased lesion), and a low (3.3 percent) rate of major adverse cardiac events (MACE) in 30 patients out to one year.

14 Mar 2008

Anticoagulant bivalirudin following angioplasty in heart attack patients reduces adverse events and bleeding

Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.

24 Oct 2007

Review of percutaneous valve therapy

Researchers at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation (CRF), will present new studies evaluating a rapidly advancing field within interventional cardiology: percutaneous procedures to repair and replace defective heart valves.

24 Oct 2007

New biomaterial from Rutgers

A revolutionary, new biomaterial, developed at the New Jersey Center for Biomaterials (NJCBM) at Rutgers University, has moved from the lab bench to field testing in record time.

19 Oct 2007

Early intervention benefits women with acute coronary syndromes

Research will be reported at TCT 2007, the annual scientific symposium of the Cardiovascular Research Foundation (CRF), that demonstrates that early intervention saves lives in women who have a heart attack or unstable chest pain.

19 Oct 2007

Landmark stent trial to be presented at TCT 2007

The Cardiovascular Research Foundation (CRF) will release results of its landmark research study, HORIZONS AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) at the nineteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington, D.C.

16 Oct 2007

UF researchers test stem cell therapy for heart patients

University of Florida doctors on Wednesday (Oct. 3) treated their first patient enrolled in a new study designed to test whether injecting stem cells into the heart helps restore blood flow to the organ by prompting new blood vessels to grow.

4 Oct 2007

How to optimally prepare a patient for planned coronary angiography and subsequent angioplasty?

A Czech study compared two anti-clotting treatment regimens, currently used before coronary angiography / angioplasty to find the optimal balance between preventing ischemic versus bleeding complications of these procedures. The study was conducted in five Czech tertiary cardiology centers.

3 Sep 2007

Morgan Stanley Children's Hospital performs transcatheter pulmonary valve replacement

A breakthrough new procedure may improve quality of life for children and adults with a common type of congenital heart defect that interferes with the body's ability to oxygenate blood through the lungs.

24 Aug 2007

Discussion on the explosive growth and the potential risks of drug-eluting stents

The Summer 2007 issue of The American Heart Hospital Journal explores one of the pivotal issues in cardiology, the drug-eluting stent (DES).

9 Aug 2007

Women's mortality rates for cardiovascular disease differ widely among hospitals

Women treated for cardiovascular disease at the nation's best- performing hospitals have a 39 percent lower risk-adjusted mortality rate when compared with women at the nation's poorest-performing hospitals, according to the fourth annual HealthGrades Women's Health Outcomes in U.S. Hospitals study.

26 Jun 2007

Obese heart attack patients more likely to survive after treatment than normal weight patients

Obese and very obese patients have a lower risk of dying after they have been treated for heart attacks than do normal weight patients, according to research published in the European Heart Journal today (Wednesday 20 June).

20 Jun 2007